HIV / AIDS in the News

Gilead presents new HIV research data at EACS 2025 – driving scientific innovation in treatment and prevention - European AIDS Treatment Group

 

Memphians work to build a healthier city at HIV awareness summit - localmemphis.com

 

Merck announces new data from Phase 3 trials evaluating the investigational HIV regimen doravirine/islatravir - European AIDS Treatment Group

 

An evolution in HIV storytelling and the LTC voices that matter - McKnight's Long-Term Care News

 

NHS introduces first long-acting HIV jab to prevent the virus - The Times

 

National Latinx AIDS Awareness Day 2025 - POZ - Health, Life and HIV

 

Providers counter ‘genuine lack of education’ to build HIV competence, confidence among LTC caregivers - McKnight's Long-Term Care News

 

German researchers find highly effective HIV antibody - DW

 

German researchers find highly effective HIV antibody - DW

 

Investigational Two-Drug HIV Regimen Shows Minimal Impact on Weight and Lipids in Phase 3 Trials - Patient Care Online

 

Interview: UNAIDS chief calls for continued global solidarity to end AIDS - Xinhua

 

Twice-Yearly Lenacapavir Could Be an Option for Initial HIV Treatment - POZ - Health, Life and HIV

 

Police arrest HIV activists who delivered "body bags" to GOP Sen. Susan Collins - LGBTQ Nation

 

Shelby County sees surge in HIV cases, health officials seek solutions - WREG.com

 

Shelby County sees surge in HIV cases, health officials seek solutions - Yahoo

 

FDA Approves 1-Minute HIV Self-Test - Pharmacy Times

 

Atlanta: The Heartbeat and History of an Epidemic Still Fighting to Be Won - POZ - Health, Life and HIV

 

Project unearths voices from one of the world's first HIV/AIDS service organizations - Medical Xpress

 

OP-ED – A Letter to Julie McKnight: On Legacy, Love, and the Fight Against HIV - GLAAD

 

MK-8527 HIV PrEP monthly pills - Specialty Pharmacy Continuum

 

MK-8527 HIV PrEP monthly pills - Specialty Pharmacy Continuum

 

Gilead to present data on potential first weekly oral treatment for HIV - Clinical Trials Arena

 

Merck's New HIV Treatment Works As Well As Top Drug In Late Trials - Benzinga

 

Gilead highlights HIV pipeline at European AIDS Conference - The Pharma Letter

 

Local leaders unite to address HIV awareness on National Latinx AIDS Awareness Day - WCIV

 

Switching to Merck’s DOR/ISL in HIV had 'minimal impact on weight and body composition - The Pharma Letter

 

A reader asked the Ethicist: I'm an HIV-positive gay man who protests regularly. My liberal friend, married to a Trump supporter, shares my fears about the U.S. but avoids protests; she only shares her views online. Her apathy feels hypocritical. Should…

 

Remembering HIV/AIDS in the illness's awareness month - Yahoo News UK

 

Pharmacy Owners Plead Guilty in Medicaid Fraud Involving Unregulated HIV Medications - HMP Global Learning Network

 

Immunotherapy approach offers hope for long-term HIV control without daily medication - Medical Xpress